Most Recent
Australian automotive electronics developer Directed Electronics OE has won access to documents seized from rivals it claims misappropriated its confidential information and infringed its copyright to gain $3.6 million in secret commissions.
An appeals court has dashed the hopes of three group members of a resolved class action over managed investment schemes operated by agribusiness Great Southern Group who sought more time to appeal approval of the settlement deed, which put them on the hook for repaying their loans to Bendigo and Adelaide Bank.
Global engineering firm CIMIC Group has been hit with costs after a last-minute subpoena of three new potential witnesses caused the three-week trial that was due to commence later this month to be vacated.
Mining firm Mach Energy is facing legal action from its former managing director over $20 million in shares allegedly owed under an equity incentive scheme.
A judge who hit Pitcher Partners with a $5.6 million damages ruling over an accounting error concealed from corporate client Neville's Bus Service was wrong to hold that the transport operator's losses flowing from the error were real, the firm has argued.
A rugby player has sued the Australian Rugby League Commission after he was barred from playing while he faces sex assault charges.
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
An appeals court has overturned a ruling awarding $2 million in compensation to United Petroleum after the state government compulsorily acquired land on which the petrol retailer operated a service station and restaurant.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.